Treatment innovations for poverty-related diseases (2017)

This Call for proposals provides funding for the clinical evaluation and development of new and innovative drug candidates for HIV/AIDS, malaria, tuberculosis, diarrhoeal infections or lower respiratory infections, including co-infections.

Preventing TB relapse and chronic lung disease: a proof-of-concept, double-blind, randomised, placebo-controlled trial to evaluate the safety and efficacy of pravastatin to reduce inflammation after TB treatment completion in HIV-infected and HIV-uninfected adults measured by FDG-PT/CT

University of Cape Town (UCT), Cape Town, South Africa, with partners from Germany, Namibia, Switzerland, and United Kingdom
Project coordinator: Dr Reto Guler (UCT, South Africa)
Starting date: 1 January 2019
Duration: 48 months
EDCTP grant amount: EUR 4,945,770
Grant agreement: RIA2017T-2004